Literature DB >> 34993936

Targets and Strategies for Cancer Immunoprevention.

Nese Unver1, Chirayu Mohindroo2.   

Abstract

The immune system plays a key role in cancer prevention, initiation, and progression. Antitumoral immune responses can be boosted by harnessing antitumorigenic immune activators and/or blocking tumorigenic proinflammatory factors. Here we define these targets as well as the strategies that could be developed for effective cancer immunoprevention.
© 2022. The Author(s).

Entities:  

Keywords:  Antitumoral immune response; Cancer immunoprevention; Immune surveillance; Immunotherapy; Tumorigenic factors

Mesh：

Substances：

Year:  2022        PMID： 34993936     DOI： 10.1007/978-1-0716-2014-4_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  47 in total

Review 1.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 2.  Castleman's disease: from basic mechanisms to molecular therapeutics.

Authors:  Hazem E El-Osta; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-03-25

3.  CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.

Authors:  Rong Rong Huang; Jason Jalil; James S Economou; Bartosz Chmielowski; Richard C Koya; Stephen Mok; Hooman Sazegar; Elizabeth Seja; Arturo Villanueva; Jesus Gomez-Navarro; John A Glaspy; Alistair J Cochran; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2011-05-10       Impact factor: 12.531

Review 4.  Interleukin-8 in cancer pathogenesis, treatment and follow-up.

Authors:  Carlos Alfaro; Miguel F Sanmamed; María E Rodríguez-Ruiz; Álvaro Teijeira; Carmen Oñate; Álvaro González; Mariano Ponz; Kurt A Schalper; José L Pérez-Gracia; Ignacio Melero
Journal:  Cancer Treat Rev       Date:  2017-08-31       Impact factor: 12.111

Review 5.  Emerging strategies for cancer immunoprevention.

Authors:  J C Roeser; S D Leach; F McAllister
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

Review 6.  IL-6 in inflammation, immunity, and disease.

Authors:  Toshio Tanaka; Masashi Narazaki; Tadamitsu Kishimoto
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-04       Impact factor: 10.005

Review 7.  Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.

Authors:  Peleg Rider; Yaron Carmi; Idan Cohen
Journal:  Int J Cell Biol       Date:  2016-12-19

Review 8.  Cancer Immunoprevention and Public Health.

Authors:  Sandeep K Singh; Mehmet Tevfik Dorak
Journal:  Front Public Health       Date:  2017-05-08

Review 9.  The Chemokine CXCL8 in Carcinogenesis and Drug Response.

Authors:  Dominique Gales; Clarence Clark; Upender Manne; Temesgen Samuel
Journal:  ISRN Oncol       Date:  2013-10-09

Review 10.  IL-1 and IL-1 regulatory pathways in cancer progression and therapy.

Authors:  Alberto Mantovani; Isabella Barajon; Cecilia Garlanda
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.